Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

darren_taylor1

Living with multiple ‘invisible’ conditions

May 26, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, patient experience, rare disease

Darren Taylor lives with a range of conditions including Dercum’s disease, cystic fibrosis, fibromyalgia with chronic fatigue, and Tietze syndrome, …
Feature
4223373030_df7722f9f7_c

Harvard study suggests monkeys develop immunity after receiving COVID-19 vaccines

May 21, 2020 Research and Development COVID-19, vaccine coronavirus

“The COVID-19 pandemic has made the development of a safe, effective, and deployable vaccine a critical global priority”, said researchers …
News
covid

Pharmafile.com’s weekly COVID-19 news round-up

May 20, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Trump, coronavirus

Trump continues to play a key role in the unfolding COVID-19 pandemic, with the US currently coping with the largest …
News
mit

MIT-developed algorithm seeks to accelerate drug approvals during COVID-19 pandemic

May 20, 2020 Research and Development, Sales and Marketing COVID-19, MIT, coronavirus, regulatory

A study emerging from the Massachusetts Institute of Technology (MIT) and published in the Harvard Data Science Review has detailed strategies …
News
ai

New research outlines guidelines for the ethical use of AI in healthcare

May 20, 2020 Research and Development AI, coronavirus

A new study published in The Lancet has called on the global health community to establish guidelines to develop and …
News

Nanotechnology could be used to assess mortality risk in COVID-19 patients

May 20, 2020 Research and Development COVID-19, coronavirus, nanotechnology

Doctors could use nanotechnology to assess the morality risk from COVID-19, according to research from Michigan State University. Morteza Mahmoudi, …
News
diabetes_3

Type 1 diabetics more likely to die from COVID-19 than type 2, according to the NHS

May 20, 2020 Research and Development COVID-19, Diabetics, coronavirus, diabetes

People suffering type 1 diabetes are far more likely to die of coronavirus than those with type 2, according to …
News
moderna-605x340

Interim data for Moderna’s COVID-19 vaccine shows glimmers of hope

May 19, 2020 Manufacturing and Production, Research and Development COVID-19, Moderna, Vaccine, coronavirus, pharma

Biotech firm Moderna has unveiled interim data from its Phase 1 trial of mRNA-1273, its vaccine against SARS-CoV-2, the virus …
News
shutterstock

New study on COVID-19 immune response shows promise for vaccine development

May 18, 2020 Research and Development, Sales and Marketing COVID-19, coronavirus, pharma

Researchers at the labs of Dr Alessandro Sette and Dr Shane Crotty at California’s La Jolla Institute for Immunology have …
News
drrrr

White House announces Dr Moncef Slaoui, the former head of GSK’s vaccine division, as the co-leader of Operation Warp Speed

May 18, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

President Donald Trump has announced that Dr Moncef Slaoui, the former head of GlaxoSmithKline’s vaccine division, will head up Operation …
Appointment
aviv_regev

Genentech’s retiring R&D head to be replaced by MIT executive

May 15, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genentech, Roche, appointment

Michael Varney, industry veteran and Head of Research & Development at Genentech, has announced he is to leave the role …
Appointment
debs

Debra Feldman announced as Vice President, Head of Regulatory at Dyne Therapeutics

May 15, 2020 Research and Development

Dyne Therapeutics has announced the appointment of Debra Feldman as their new Vice President, Head of Regulatory. Feldman said on …
Appointment

Abbott’s COVID-19 test, used at the White House, fails to identify up to 48% of positive cases, study argues

May 15, 2020 Medical Communications, Research and Development Abbott, COVID-19, coronavirus, pharma

Abbott’s 13-minute ID NOW COVID-19 testing kits have come under scrutiny after a study from New York University (NYU) revealed …
News
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

May 15, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, top 10

The news this week continues to be dominated by COVID-19 vaccines and treatments, with the NIAID announcing the launch of …
News
janssen_latest_logo_on_sign_closer

100% of multiple myeloma patients respond to Janssen’s investigational CAR T therapy, data shows

May 14, 2020 Research and Development CAR T, CAR-T, Janssen, multiple myeloma, pharma

Janssen has revealed new Phase1b/2 findings of the efficacy of its investigational B-cell maturation antigen (BCMA)-directed chimeric antigen receptor T cell …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025